CBLL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.600390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.612200E-01
Normal-vs-Stage2
1.440210E-01
Normal-vs-Stage3
3.697600E-02
Normal-vs-Stage4
6.824800E-01
Stage1-vs-Stage2
5.104000E-01
Stage1-vs-Stage3
1.550110E-02
Stage1-vs-Stage4
1.112980E-01
Stage2-vs-Stage3
8.041500E-02
Stage2-vs-Stage4
1.743620E-02
Stage3-vs-Stage4
8.515200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.442970E-01
Normal-vs-AfricanAmerican
6.457200E-01
Normal-vs-Asian
1.359580E-01
Caucasian-vs-AfricanAmerican
2.886000E-01
Caucasian-vs-Asian
6.388600E-01
AfricanAmerican-vs-Asian
2.742400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.641410E-01
Normal-vs-Female
1.720440E-01
Male-vs-Female
8.184800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.205800E-01
Normal-vs-Age(41-60Yrs)
4.274800E-01
Normal-vs-Age(61-80Yrs)
1.060380E-01
Normal-vs-Age(81-100Yrs)
3.123900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.725800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.443800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.857800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.880130E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.899640E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.670600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.556100E-02
Normal-vs-Daily Drinker
5.338100E-02
Normal-vs-Weekly Drinker
3.103600E-01
Normal-vs-Occasional Drinker
1.551630E-01
Normal-vs-Social Drinker
5.190000E-01
Non Drinker-vs-Daily Drinker
8.105800E-01
Non Drinker-vs-Weekly Drinker
4.021800E-01
Non Drinker-vs-Occasional Drinker
3.749200E-01
Non Drinker-vs-Social Drinker
5.850300E-02
Daily Drinker-vs-Weekly Drinker
3.111000E-01
Daily Drinker-vs-Occasional Drinker
2.594200E-01
Daily Drinker-vs-Social Drinker
3.858400E-02
Weekly Drinker-vs-Occasional Drinker
9.181600E-01
Weekly Drinker-vs-Social Drinker
4.260800E-01
Occasional Drinker-vs-Social Drinker
2.713600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.440770E-01
Normal-vs-Grade 2
3.365500E-02
Normal-vs-Grade 3
5.059600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.264800E-01
Grade 1-vs-Grade 3
8.123000E-01
Grade 1-vs-Grade 4
1.440770E-01
Grade 2-vs-Grade 3
8.774800E-01
Grade 2-vs-Grade 4
3.365500E-02
Grade 3-vs-Grade 4
5.059600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.085780E-01
Normal-vs-NonDiabetic
1.178160E-01
Diabetic-vs-NonDiabetic
3.140200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.367000E-01
Normal-vs-NoPancreatitis
1.086800E-01
Pancreatitis-vs-NoPancreatitis
4.920400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.328400E-01
Normal-vs-N1
1.399000E-01
N0-vs-N1
6.987400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.361000E-01
Normal-vs-TP53-NonMutant
4.992200E-01
TP53-Mutant-vs-TP53-NonMutant
5.915400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
